The FTSE All-Share Total Return Index (adjusted) returned 7.4% in March as the economic recovery gathered pace. It should be noted that the UK looks to be emerging from recession very quickly now. We have therefore been seeking out UK-facing assets for the last few months and will continue to do so.
Name | % Net Assets |
---|---|
BP | 5.2% |
Royal Dutch Shell | 4.9% |
HSBC | 4.9% |
GlaxoSmithKline | 4.7% |
AstraZeneca | 4.4% |
Vodafone Group | 4.1% |
Centrica | 3.5% |
Rio Tinto | 3.2% |
Standard Life | 3.1% |
3i | 2.6% |
Key | % Net Assets |
---|---|
BP | 5.2% |
Royal Dutch Shell | 4.9% |
HSBC | 4.9% |
GlaxoSmithKline | 4.7% |
Other | 80.3% |
Date | 21-Nov-2024 |
---|---|
NAV | 192.40p |
Currency | GBP |
Change | 0.100p |
% | 0.05% |
YTD change | 11.30p |
YTD % | 6.24% |
Fund Inception | 16/06/2008 |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.25% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research